Jeffrey Berkowitz

Jeffrey Berkowitz 0065

Board member

Elected to the Board in 2019 and regarded as an independent board member.

  • Member of the Audit Committee

Special competencies

Global executive with extensive branded and generic pharmaceutical, retail pharmacy, wholesale drug distribution, speciality, payor and healthcare services leadership experience in P&L accountable roles.

Current positions

CEO and Director of Real Endpoints. Board member of H. Lundbeck A/S, Esperion Therapeutics, Inc. and Uniphar PLC.

Share profile